Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Tissue Inhibitor of Metalloproteinase-1 Is Confined to Tumor-Associated Myofibroblasts and Is Increased With Progression in Gastric Adenocarcinoma

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Expression of the Ly6/uPAR-domain proteins C4.4A and Haldisin in non-invasive and invasive skin lesions

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. The Urokinase Receptor Homolog Haldisin Is a Novel Differentiation Marker of Stratum Granulosum in Squamous Epithel

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. YKL-40 is differentially expressed in human embryonic stem cells and in cell progeny of the three germ layers

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Evaluation of algorithm development approaches: Development of biomarker panels for early detection of colorectal lesions

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Prognostic factors for relapse in patients with clinical stage I testicular cancer: protocol for a Danish nationwide cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. GPIHBP1 and Lipoprotein Lipase, Partners in Plasma Triglyceride Metabolism

    Research output: Contribution to journalReviewResearchpeer-review

  4. Evolution and Medical Significance of LU Domain-Containing Proteins

    Research output: Contribution to journalReviewResearchpeer-review

View graph of relations

The tissue inhibitor of metalloproteinase-1 (TIMP-1) inhibits the extracellular matrix-degrading activity of several matrix metalloproteinases, thereby regulating cancer cell invasion and metastasis. Studies describing the expression pattern and cellular localization of TIMP-1 in gastric cancer are, however, highly discordant. We addressed these inconsistencies by performing immunohistochemistry and in situ hybridization analyses in a set of 49 gastric cancer lesions to reexamine the TIMP-1 localization. In addition, we correlated these findings to clinicopathological parameters. We show that strong expression of TIMP-1 protein and mRNA was observed in a subpopulation of stromal fibroblast-like cells at the periphery of the cancer lesions. In a few cases, a small fraction of cancer cells showed weak expression of TIMP-1 protein and mRNA. The stromal TIMP-1-expressing cells were mainly tumor-associated myofibroblasts. In the normal-appearing mucosa, scattered TIMP-1 protein was only found in chromogranin A positive cells. TIMP-1-positive myofibroblasts at the invasive front of the tumors were more frequently seen in intestinal than in diffuse histological subtype cases (p=0.009). A significant trend to a higher number of cases showing TIMP-1 staining in myofibroblasts with increasing tumor, node, metastasis (TNM) stage was also revealed (p=0.041). In conclusion, tumor-associated myofibroblasts are the main source of increased TIMP-1 expression in gastric cancer.

Original languageEnglish
JournalThe journal of histochemistry and cytochemistry : official journal of the Histochemistry Society
Volume64
Issue number8
Pages (from-to)483-94
Number of pages12
ISSN0022-1554
DOIs
Publication statusPublished - Aug 2016

    Research areas

  • Journal Article

ID: 48277868